In a wide-ranging interview, Mitchell discussed the Purchaser Business Group Health’s health data demonstration project, ...
It was announced today that Jefferson Health, Penn Medicine and Temple Health have been selected as the 2026 Clinical Care ...
Breast cancer screening based on individual risk rather than annual screening is safe, effective and preferred by patients, ...
Shekhar Khera, senior vice president, product management at RxBenefits, discusses the role of artificial intelligence in ...
An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...
BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...
Although three-fourths (76%) of breast cancer patients are exposed to cancer misinformation, perpetuating fear in 38%, it did ...
In 2026, AI will continue threading itself into behavioral health, and the bar will rise sharply for what counts as ...
The Pharmaceutical Care Management Association (PCMA) has named David Marin, J.D., as its new president and CEO, effective ...
Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...
Patients will demand transparency and value, expecting personalized, data-rich experiences with clear prices and quality ...
At the 2025 AMCP annual meeting in Houston, John M. O'Brien, Pharm.D., M.P.H., president and CEO of the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback